Case Study | July 24, 2012

New Positioning System Facilitates Cancer Treatments

Agnesian HealthCare’s Protura robotic patient positioning system helps it provide precise radiation therapy to patients in its local community

New Positioning System Facilitates Cancer Treatments

The Protura positioning system integrates with existing IGRT solutions and the linac to provide all-in-one motion management. The patient can be positioned with 6 degrees of freedom corrections from outside the treatment room.

Each year, community cancer centers treat about 85 percent of cancer patients in the United States.1 Agnesian HealthCare Cancer Care Services brings exceptional cancer care closer to patients through its Central Wisconsin Cancer Program (CWCP). Agnesian HealthCare’s Fond du Lac location is one of a handful of image-guided radiation therapy (IGRT) and stereotactic body radiation therapy (SBRT) providers in the state, and it is the only facility in Wisconsin to have installed a robotic 6DOF patient positioning system.

The Protura robotic patient positioning system, a product of CIVCO Medical Solutions, is capable of positioning patients in 6DOF with sub-millimeter and sub-degree accuracy. Agnesian HealthCare has used it to facilitate IGRT and to implement SBRT treatments.

“SBRT requires highly conformal treatment planning as well as the tools to confidently deliver that treatment,” said Tim Lemond, Agnesian HealthCare chief physicist. “That means sub-millimeter and sub-degree accuracy and a robotic 6DOF table with the ability to correct for translational and rotational errors. The Protura system meets these requirements and enables us to deliver high-quality SBRT treatments.”

Agnesian HealthCare’s Cancer Care Services sees patients from a wide area of East Central Wisconsin. The delivery of SBRT at a community center allows these patients to receive highly advanced treatment closer to home.

“With the addition of the 6DOF system, we are bringing the highest technology and the best treatment techniques to patients in our area,” said Heather Bowen, MBA, RT (R)(T)(CT), radiation oncology supervisor at Agnesian HealthCare. “These patients get to receive treatment near their families and near their jobs. It’s unique for us to be able to provide that without requiring our patients to travel.” Agnesian HealthCare associates and providers are proud to provide this level of care.

Clinically, the addition of the robotic 6DOF system has improved treatment confidence and patient care. “Whether we are treating head and neck cases with intensity-modulated radiation therapy (IMRT) or delivering SBRT, accurately positioning the patient gives us clinical confidence that we are using the data from 3-D imaging to deliver treatment only to the tumor,” said Timothy Korytko, M.D., a board-certified radiation oncologist with Agnesian HealthCare. “We’re able to use smaller margins and minimize the side effects of treatment. Using the Protura system provides the best results and care for our patients.”

Through the addition of a 6DOF robotic patient positioning system, Agnesian HealthCare CWCP has brought cutting-edge radiation treatment technology into a community cancer care setting, providing an example for community cancer centers across the country.

Reference:
1. http://ncccp.cancer.gov/Media/FactSheet.htm

Case study supplied by CIVCO Medical Solutions.

Related Content

An example of the MRI scans showing long-term and short-term survival indications. #MRI

An example of the MRI scans showing long-term and short-term survival indications. Image courtesy of Case Western Reserve University

News | Magnetic Resonance Imaging (MRI) | February 21, 2020
February 21, 2020 — ...
Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure

Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure. This picture shows a circle of hydrogel that was irradiated on the left half, which is slightly pink; whereas the right half of the gel is not irradiated and remains colorless.

News | Radiation Therapy | February 18, 2020
February 18, 2020 — More than half of all cancer patients undergo radiation therapy and the dose is critical.
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
The radiation therapy market is projected to grow in through 2026

Image courtesy of Accuray

News | Proton Therapy | February 10, 2020
February 10, 2020 — Amid technological advancement, and notable research and development activities, the global ...
SIR President Laura Findeiss, M.D., FSIR

SIR President Laura Findeiss, M.D., FSIR

News | Interventional Radiology | February 09, 2020
February 9, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the...
Accuray TomoTherapy total body irradiation
News | Radiation Therapy | February 07, 2020
February 7, 2020 — Accuray Incorporated announced that two new studies demonstrate the benefits of the ...
Purdue University-discovered fluorescent markers to target and illuminate cancer during surgery, has announced the results of a multi-institutional Phase 2 clinical trial in which outcomes were improved for 26 percent of patients undergoing pulmonary resection for non-small-cell lung cancer (NSCLC)

A Purdue discovery being developed by On Target Laboratories Inc., illuminates lung cancer cells on a patient during surgery. The “fluorescent markers” help medical professionals identify and remove cancer cells during surgery and is shown to improve outcomes. The technology is beginning Phase 3 clinical trials. (Photo provided by On Target)

News | Molecular Imaging | February 06, 2020
February 6, 2020 — ...
The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy

An oxygen map image recovered from a mouse undergoing radiation therapy. The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy (red). Image courtesy of Brian Pogue, PhD

News | Radiation Therapy | February 03, 2020
February 3, 2020 — Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful.
News | Clinical Trials | February 03, 2020
February 3, 2020 — Melding the genetic and cellular analysis of tumors with how they appear in medical images could g